IRIS Accounts Production v25.1.3.33 08617021 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 100.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh086170212023-09-30086170212024-09-30086170212023-10-012024-09-30086170212022-09-30086170212022-10-012023-09-30086170212023-09-3008617021ns15:EnglandWales2023-10-012024-09-3008617021ns14:PoundSterling2023-10-012024-09-3008617021ns10:Director12023-10-012024-09-3008617021ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3008617021ns10:SmallEntities2023-10-012024-09-3008617021ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3008617021ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3008617021ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3008617021ns10:FullAccounts2023-10-012024-09-3008617021ns10:OrdinaryShareClass12023-10-012024-09-3008617021ns10:Director22023-10-012024-09-3008617021ns10:RegisteredOffice2023-10-012024-09-3008617021ns5:CurrentFinancialInstruments2024-09-3008617021ns5:CurrentFinancialInstruments2023-09-3008617021ns5:ShareCapital2024-09-3008617021ns5:ShareCapital2023-09-3008617021ns5:RetainedEarningsAccumulatedLosses2024-09-3008617021ns5:RetainedEarningsAccumulatedLosses2023-09-3008617021ns5:PlantMachinery2023-09-3008617021ns5:PlantMachinery2023-10-012024-09-3008617021ns5:PlantMachinery2024-09-3008617021ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3008617021ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3008617021ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 08617021 (England and Wales)













UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

DR PARAMESH BANERJI'S LIFE SCIENCES LTD

DR PARAMESH BANERJI'S LIFE SCIENCES LTD (REGISTERED NUMBER: 08617021)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DR PARAMESH BANERJI'S LIFE SCIENCES LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: Dr P Banerji
Mrs S Dutta





REGISTERED OFFICE: 10 John Street
London
WC1N 2EB





REGISTERED NUMBER: 08617021 (England and Wales)





ACCOUNTANTS: Oury Clark Chartered Accountants
Herschel House
58 Herschel Street
Slough
Berkshire
SL1 1PG

DR PARAMESH BANERJI'S LIFE SCIENCES LTD (REGISTERED NUMBER: 08617021)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
CURRENT ASSETS
Debtors 5 472 697
Cash at bank 3,990 278
4,462 975
CREDITORS
Amounts falling due within one year 6 947,795 857,658
NET CURRENT LIABILITIES (943,333 ) (856,683 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(943,333

)

(856,683

)

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings (943,433 ) (856,783 )
SHAREHOLDERS' FUNDS (943,333 ) (856,683 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 June 2025 and were signed on its behalf by:





Dr P Banerji - Director


DR PARAMESH BANERJI'S LIFE SCIENCES LTD (REGISTERED NUMBER: 08617021)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Dr Paramesh Banerji's Life Sciences Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The accounts have been prepared on the going concern basis notwithstanding the company has net liabilities as at the year end. This basis assumes the ongoing support of the parent company, such support being pledged for a period in excess of 12 months and 1 day from the date these financial statements are signed.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost less any accumulated depreciation.
Depreciation is provided at the following annual rates in order to write off the asset over its estimated useful life.
P&M and Computer equipment - 3 years straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

DR PARAMESH BANERJI'S LIFE SCIENCES LTD (REGISTERED NUMBER: 08617021)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2. ACCOUNTING POLICIES - continued

Financial instruments
Basic financial instruments as covered by Section 11 of FRS102 are measured at amortised cost. The company does not have any other financial instruments as covered by Section 12 of FRS102.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2023 3,490
Disposals (3,490 )
At 30 September 2024 -
DEPRECIATION
At 1 October 2023 3,490
Eliminated on disposal (3,490 )
At 30 September 2024 -
NET BOOK VALUE
At 30 September 2024 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Other debtors 472 697

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors 499 4,554
Amounts owed to group undertakings 906,622 813,332
Taxation and social security 1,631 1,450
Other creditors & accruals 39,043 38,322
947,795 857,658

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
100 Ordinary £100 100 100

DR PARAMESH BANERJI'S LIFE SCIENCES LTD (REGISTERED NUMBER: 08617021)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. RELATED PARTY DISCLOSURES

The balance owed at the year end to P. Banerji Mihijam Pharmaceuticals is £2,950 (2023: £2,950).

The balance owed at the year end to Dr Paramesh Banerji is £28,171 (2023: £28,171).

9. ULTIMATE CONTROLLING PARTY

The controlling party is Dr Paramesh Banerji by virtue of his majority shareholding in the parent company.

Dr Paramesh Banerji Group Ltd is regarded by the directors as being the company's parent company.